我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

替罗非班在急性心肌梗死溶栓不同时期应用的疗效

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2014年第3期
页码:
310-312，316
栏目:
临床研究
出版日期:
2014-03-20

文章信息/Info

Title:
Application of tirofiban in different periods of thrombolysis in acute myocardial infarction
作者:
潘 莹; 段 雯; 曾宪钦; 张志远
(深圳市龙岗区人民医院心血管内科，广东 深圳 518172)
Author(s):
PAN Ying;  DUAN Wen;  ZENG Xian qin;  ZHANG Zhi yuan
(Cardiovascular Department, Longgang District People’s Hospital, Shenzhen 518172, Guangdong, China)
关键词:
替罗非班; 心肌梗死; 急性; 溶栓; 补救
Keywords:
tirofiban;  acute myocardial infarction;  thrombolysis;  rescue
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
目的:观察替罗非班在急性心肌梗死溶栓不同时期应用的疗效及安全性。方法:87例ST段抬高型急性心肌梗死患者随机分为常规溶栓组（30例）、早期使用替罗非班组（溶栓前给药28例）和补救替罗非班组（溶栓失败后给药29例）。采用判断溶栓再通间接指标来评估3组患者梗死相关血管的再通率；观察患者出血的发生率及24 h内并发症。结果:早期应用组血管再通率明显提高，心肌肌钙蛋白I浓度峰值、肌酸激酶同工酶浓度峰值和达峰时间与常规溶栓组、补救应用组比较，明显降低和缩短(P<0.05)，应用替罗非班后较常规溶栓组胸痛持续时间缩短，ST段下降时间提前(P<0.05)。出血的发生率无统计学意义。在24 h内并发症方面，3组无明显统计学差异。结论:溶栓联合替罗非班，特别是早期应用者可以提高溶栓成功率，减轻心肌损害而不会增加并发症和出血风险。
Abstract:
AIM:To assess the safety and efficacy of tirofiban in different periods of thrombolysis in acute myocardial infarction. METHODS: Eighty-seven patients with ST-segment elevation myocardial infarction (STEMI) were randomly divided into three groups: routine thrombolysis group (thrombolysis only, n=30), pre-treatment tirofiban group (tirofiban before thrombolysis, n=28) and rescue tirofiban group (tirofiban after thrombolysis failure, n=29). The perfusion indirect indexes of thrombolysis were observed in the three groups. Major cardiovascular complications in 24 h and hemorrhagic events were also observed. RESULTS: Rapid reperfusion was observed in the pre-treatment tirofiban group. Peak value and peak time of cardiac troponin I (cTNI), creatinine kinase and MB isoenzyme (CK-MB) in the pretreatment tirofiban group were lower and shorter than those in the routine thrombolysis group and rescue tirofiban group. Administration of tirofiban before or after thrombolysis more effectively shortened the duration of chest pain and lessened the ST segment descent compared with those in the routine thrombolysis group. But no signifcant difference was found in hemorrhage events and cardiovascular complications during 24 h among the three groups. CONLUSION: Tirofiban combined with thrombolysis, especially administration of tirofiban before thrombolysis, could improve the success rate of thrombolysis and lessen the myocardial injury without increasing cardiovascular complications and hemorrhage risks.

参考文献/References

[1]Montalescot G,Sideris G,Meuleman C,et al.A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes:the ALBION (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial[J].J Am Coll Cardiol,2006,48(5):931-938.
[2]周玉杰,汤楚中.冠心病规范化治疗[M].北京:北京大学出版社,2009:33.
[3]陈灏珠.心脏病学[M].第4版.北京:人民卫生出版社,2006:853.
[4]Rebeiz AG,Johanson P,Green CL,et al.Comparison of ST-segment resolution with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy versus fibrinolytic alone (data from four clinical trials)[J].Am J Cardiol,2005,95(5):611-614.
[5]Ronner E,van Domburg RT,van den Brand MJ,et al.Platelet GP IIb/IIIa receptor blockers for failed thrombolysis in acute myocardial infarction, alone or as adjunct to other rescue therapies; single centre retrospective analysis of 548 consecutive patients with acute myocardial infarction[J].Eur Heart J,2002,23(19):1529-1537.
[6]Vetrano A,Carotenuto R,Corsini F,et al.Effectiveness of tirofiban for failed thrombolysis during acute myocardial infarction[J].Am J Cardiol,2004,93(7):914-916.
[7]Califf RM.Glycoprotein IIb/IIIa blockade and thrombolytics:early lessons from the SPEED and GUSTO IV trials[J].Am Heart J,1999,138(1 Pt 2):S12-S15.

备注/Memo

备注/Memo:
收稿日期：2013-09-24.
通讯作者：潘莹，主治医师，硕士生 Email：nacypanying@163.com
更新日期/Last Update: 2014-03-21